Supplements

New HIV Drug Helps 74-Year-Old Woman Thrive 30 Years After Diagnosis — What This Means for Patients

Barbara Roberts was 44 years old when she received a life-changing diagnosis in December 1996. What started as what she thought was a stubborn flu turned out to be HIV. At the time, she felt terrified. “It was like a death sentence,” she recalls.

Today, at age 74, Roberts is not only alive but thriving. She credits a new FDA-approved medication called Idvynso with helping her manage her condition with just one pill a day. Her story highlights how far HIV treatment has come — and what it means for the millions of people living with the virus today.

From a ‘Death Sentence’ to a Manageable Condition

In 1996, when Roberts was diagnosed, the outlook for people with HIV was grim. According to statistics from that era, a 20-year-old diagnosed with HIV had a total life expectancy of just 39 years. By 2011, that number had jumped to about 70 years — a dramatic improvement driven by better medications.

Roberts’ initial reaction was shock and fear. She had gone to the emergency room with a high fever and sweating that wouldn’t go away. Doctors first sent her home with antibiotics, but when she returned still feeling unwell, they admitted her for three days of testing.

“It never occurred to me that that’s what was going wrong with me,” she says.

After her diagnosis, Roberts left the hospital with a medication regimen and began visiting an HIV clinic for support. The staff there helped calm her fears, she says, and for a while, her symptoms improved.

But a year later, she faced a new crisis. She became extremely tired, experienced shortness of breath, and developed nosebleeds. Her skin on her hands and the bottoms of her feet darkened. A severe nosebleed sent her back to the emergency room, where doctors discovered her blood platelets were dangerously low.

For 25 days straight, Roberts received blood and platelet transfusions in the hospital. Doctors eventually figured out that one of her HIV medications was causing the problem. They adjusted her treatment, and she has not had a similar crisis since.

What Experts Say About HIV Today

HIV is now considered a chronic, manageable disease — much like diabetes or high blood pressure. But that doesn’t mean it’s easy. Dr. Debbie Hagins, Roberts’ rheumatologist and the medical director of the Coastal CARE Centers in southeast Georgia, has been treating HIV patients since 1989. She has seen the revolution in treatment firsthand.

“I remember patients who felt that the treatment was worse than the disease,” Hagins says. “They gave up their dreams of having a family, of traveling, of pursuing a career.”

Today, she says, those limitations no longer apply for many patients. But she also stresses that HIV still comes with increased risks for other health problems, including bone disease, heart disease, kidney disease, and accelerated aging. That’s why finding the right medication — and the simplest regimen — is so important.

“Prescribing the least amount of medication and at the lowest dose possible to achieve the desired goal is always the objective,” Hagins explains.

A New Option: Idvynso

In 2021, Hagins asked Roberts if she wanted to join a clinical trial for Idvynso, a daily two-drug single-tablet treatment for people with HIV who are virally suppressed. Roberts didn’t hesitate.

“I felt it was a privilege for her to ask me to be in this study,” Roberts says.

The appeal was simple: Instead of taking multiple pills each day, she could take just one. The only side effect she noticed was vivid dreams for about two weeks. After that, she says, “it’s been smooth sailing.”

Roberts continues in the trial as part of an open-label extension, where researchers collect more data on the drug’s long-term safety. Today, Idvynso is the only medication she takes, aside from vitamin D and folic acid supplements.

At 74, Roberts deals with age-related back pain and arthritis, but she says she’s grateful not to have other chronic conditions that require medication. She knows others haven’t been as lucky.

“I hear of people having to take many different medications in a day because their HIV had caused them so many other problems, like organs breaking down and skin tissue issues,” she says. “If this could help me, why shouldn’t I be able to help someone else?”

Why More Treatment Options Matter

Hagins emphasizes that while current HIV medications are effective, more options are still needed. People with HIV require lifelong treatment, and over time, side effects can emerge. As people age, their bodies respond differently to medications.

“Our currently FDA-approved medications have not changed in their efficacy, but people change,” Hagins says. “As we age, our bodies respond and react to illnesses and their treatments differently with each decade of life.”

She notes that it’s standard medical practice to review a patient’s medications during office visits and consider dose reductions, changes, or discontinuations as needed. Having a variety of treatment options allows doctors to tailor care to each patient’s changing needs.

Overcoming Stigma: A Personal Journey

When Roberts was first diagnosed, she kept her condition private. She told only close family members. “It was just a private thing that I had and that I managed because I didn’t want people to think of me with all the different stigmas that were attached to it,” she says.

That changed when she met Johnny L. Roberts on Labor Day in 1997. At first, their relationship was casual. But as it became serious, she grew afraid. She had never had to tell a partner about her HIV status before.

“He just embraced me, and he told me, ‘You’re going to be fine,’” she recalls. “He told me about the sadness that he saw in my eyes that I never thought I presented, but I guess that I did.”

Today, Roberts believes that education and understanding have helped reduce the stigma around HIV. She hopes her story encourages others to be open about their experiences.

“Sometimes it’s hard because people and places and times can be mean,” she says. “But I’m grateful that there’s more positive information now, and people are more accepting than they used to be.”

Practical Takeaways for Readers

If you or someone you love is living with HIV, here are key points to keep in mind:

HIV is a manageable condition. With modern treatment, many people live long, healthy lives. Life expectancy has dramatically improved since the 1990s.

Treatment has become simpler. Options like Idvynso allow some patients to take just one pill a day, reducing the burden of complex medication schedules.

Regular check-ups are essential. HIV increases the risk of other health problems, including heart, bone, and kidney disease. Routine monitoring helps catch issues early.

Talk to your doctor about your options. If you’re experiencing side effects or feel your current regimen isn’t working well, ask about alternatives. There are more choices than ever before.

Stigma still exists, but it’s fading. Support from loved ones and community resources can make a huge difference. Organizations like Bezzy offer online communities where people with chronic conditions can connect and share experiences.

You are not alone. Millions of people live with HIV worldwide. Advances in treatment and a growing understanding of the virus mean that a diagnosis today is far from the death sentence it once was.

Barbara Roberts’ story is a testament to resilience and the power of medical progress. At 74, she’s living proof that with the right treatment and support, people with HIV can not only survive — they can thrive.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any health decisions. Content reviewed by the HealthyMag Editorial Team.

Source: Healthline

HealthyMag Editorial Team

The HealthyMag Editorial Team is a group of health writers and researchers dedicated to delivering accurate, evidence-based health information. Our content follows strict editorial guidelines and is reviewed for medical accuracy before publication.